Search Results

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis.

• Authors : Jones, Graeme¹ (AUTHOR) ; Changhai Ding¹ (AUTHOR)

• Source: Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders. 2010, Issue 3, p81-89. 9p. 4 Charts, 3 Graphs.

Record details

FDA approves tocilizumab to treat rheumatoid arthritis.

• Authors : Thompson, Cheryl A.

• Source: American Journal of Health-System Pharmacy. 2/15/2010, Vol. 67 Issue 4, p254-254. 3/4p.

Record details

Tocilizumab.

• Source: Reactions Weekly. 7/24/2010, Issue 1311, p40-41. 2p.

Record details

Tocilizumab: risk of fatal anaphylaxis.

• Source: WHO Drug Information. 2010, Vol. 24 Issue 4, p300-301. 2p.

Record details

Tocilizumab.

• Source: Reactions Weekly. 1/9/2010 Part 1 of 2, Issue 1283, p87-87. 1/3p.

Record details

Tocilizumab-induced anaphylaxis highlighted in safety update.

• Source: Reactions Weekly. 9/25/2010, Issue 1320, p3-3. 1/5p.

Record details

Tocilizumab.

• Source: Reactions Weekly. 7/24/2010, Issue 1311, p40-40. 1/5p.

Record details

Tocilizumab cost effective in the UK.

• Source: PharmacoEconomics & Outcomes News. 7/10/2010, Issue 607, p2-2. 1/3p.

Record details

Tocilizumab.

• Source: Reactions Weekly. 5/15/2010, Issue 1301, p50-50. 1/6p.

Record details

Tocilizumab.

• Source: Reactions Weekly. 1/9/2010 Part 2 of 2, Issue 1283, p87-87. 1/3p.

Record details